Logo image of VEE.DE

VEEVA SYSTEMS INC-CLASS A (VEE.DE) Stock Fundamental Analysis

FRA:VEE - Deutsche Boerse Ag - US9224751084 - Common Stock - Currency: EUR

225.8  -2.3 (-1.01%)

Fundamental Rating

7

VEE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 12 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VEE a very profitable company, without any liquidiy or solvency issues. VEE is not overvalued while it is showing excellent growth. This is an interesting combination. This makes VEE very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

VEE had positive earnings in the past year.
In the past year VEE had a positive cash flow from operations.
Each year in the past 5 years VEE has been profitable.
Each year in the past 5 years VEE had a positive operating cash flow.
VEE.DE Yearly Net Income VS EBIT VS OCF VS FCFVEE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

VEE has a Return On Assets of 10.32%. This is amongst the best in the industry. VEE outperforms 81.82% of its industry peers.
Looking at the Return On Equity, with a value of 12.10%, VEE is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
The Return On Invested Capital of VEE (8.09%) is better than 81.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VEE is in line with the industry average of 7.76%.
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROIC 8.09%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)8.95%
ROIC(5y)10%
VEE.DE Yearly ROA, ROE, ROICVEE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 25.07%, VEE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of VEE has declined.
Looking at the Operating Margin, with a value of 24.22%, VEE belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Operating Margin of VEE has declined.
VEE has a Gross Margin (73.93%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of VEE has remained more or less at the same level.
Industry RankSector Rank
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
VEE.DE Yearly Profit, Operating, Gross MarginsVEE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VEE is destroying value.
The number of shares outstanding for VEE has been increased compared to 1 year ago.
Compared to 5 years ago, VEE has more shares outstanding
There is no outstanding debt for VEE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VEE.DE Yearly Shares OutstandingVEE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VEE.DE Yearly Total Debt VS Total AssetsVEE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

VEE has an Altman-Z score of 26.19. This indicates that VEE is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 26.19, VEE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VEE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 26.19
ROIC/WACC0.86
WACC9.45%
VEE.DE Yearly LT Debt VS Equity VS FCFVEE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 6.36 indicates that VEE has no problem at all paying its short term obligations.
VEE has a Current ratio of 6.36. This is amongst the best in the industry. VEE outperforms 100.00% of its industry peers.
VEE has a Quick Ratio of 6.36. This indicates that VEE is financially healthy and has no problem in meeting its short term obligations.
VEE's Quick ratio of 6.36 is amongst the best of the industry. VEE outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.36
Quick Ratio 6.36
VEE.DE Yearly Current Assets VS Current LiabilitesVEE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

8

3. Growth

3.1 Past

VEE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.57%, which is quite impressive.
The Earnings Per Share has been growing by 24.47% on average over the past years. This is a very strong growth
VEE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.67%.
The Revenue has been growing by 22.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.41%

3.2 Future

The Earnings Per Share is expected to grow by 16.21% on average over the next years. This is quite good.
Based on estimates for the next years, VEE will show a quite strong growth in Revenue. The Revenue will grow by 13.25% on average per year.
EPS Next Y34.83%
EPS Next 2Y20.67%
EPS Next 3Y17.47%
EPS Next 5Y16.21%
Revenue Next Year16.16%
Revenue Next 2Y14.14%
Revenue Next 3Y13.69%
Revenue Next 5Y13.25%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VEE.DE Yearly Revenue VS EstimatesVEE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEE.DE Yearly EPS VS EstimatesVEE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

VEE is valuated quite expensively with a Price/Earnings ratio of 37.32.
VEE's Price/Earnings ratio is a bit cheaper when compared to the industry. VEE is cheaper than 63.64% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.47, VEE is valued a bit more expensive.
VEE is valuated quite expensively with a Price/Forward Earnings ratio of 33.11.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VEE is on the same level as its industry peers.
VEE is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 37.32
Fwd PE 33.11
VEE.DE Price Earnings VS Forward Price EarningsVEE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

VEE's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. VEE is more expensive than 72.73% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as VEE.
Industry RankSector Rank
P/FCF 35.92
EV/EBITDA 42.28
VEE.DE Per share dataVEE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

VEE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VEE has a very decent profitability rating, which may justify a higher PE ratio.
VEE's earnings are expected to grow with 17.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)1.53
EPS Next 2Y20.67%
EPS Next 3Y17.47%

0

5. Dividend

5.1 Amount

VEE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VEEVA SYSTEMS INC-CLASS A

FRA:VEE (2/4/2025, 7:00:00 PM)

225.8

-2.3 (-1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)N/A N/A
Inst Owners83.6%
Inst Owner ChangeN/A
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap36.66B
Analysts78.42
Price Target257.22 (13.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.06%
Min EPS beat(2)3.51%
Max EPS beat(2)8.61%
EPS beat(4)4
Avg EPS beat(4)4.86%
Min EPS beat(4)3.17%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)5.83%
EPS beat(12)11
Avg EPS beat(12)4.64%
EPS beat(16)15
Avg EPS beat(16)6.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.62%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-0.6%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-0.72%
Revenue beat(12)1
Avg Revenue beat(12)-0.67%
Revenue beat(16)4
Avg Revenue beat(16)-0.19%
PT rev (1m)-2.61%
PT rev (3m)17.23%
EPS NQ rev (1m)2.69%
EPS NQ rev (3m)-2%
EPS NY rev (1m)0.08%
EPS NY rev (3m)2.54%
Revenue NQ rev (1m)0.6%
Revenue NQ rev (3m)-2.17%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 37.32
Fwd PE 33.11
P/S 14.26
P/FCF 35.92
P/OCF 35.14
P/B 6.89
P/tB 7.56
EV/EBITDA 42.28
EPS(TTM)6.05
EY2.68%
EPS(NY)6.82
Fwd EY3.02%
FCF(TTM)6.29
FCFY2.78%
OCF(TTM)6.43
OCFY2.85%
SpS15.83
BVpS32.79
TBVpS29.88
PEG (NY)1.07
PEG (5Y)1.53
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 12.1%
ROCE 11.5%
ROIC 8.09%
ROICexc 84.99%
ROICexgc 1018.55%
OM 24.22%
PM (TTM) 25.07%
GM 73.93%
FCFM 39.71%
ROA(3y)10.08%
ROA(5y)11.19%
ROE(3y)13.04%
ROE(5y)14.79%
ROIC(3y)8.95%
ROIC(5y)10%
ROICexc(3y)49.6%
ROICexc(5y)44.1%
ROICexgc(3y)317.75%
ROICexgc(5y)302.83%
ROCE(3y)12.72%
ROCE(5y)14.2%
ROICexcg growth 3Y-13.2%
ROICexcg growth 5Y-16.56%
ROICexc growth 3Y2.45%
ROICexc growth 5Y-14.96%
OM growth 3Y-11.02%
OM growth 5Y-6.82%
PM growth 3Y-5%
PM growth 5Y-3.55%
GM growth 3Y-0.34%
GM growth 5Y-0.06%
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 61.8%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 158.26%
Profit Quality 158.39%
Current Ratio 6.36
Quick Ratio 6.36
Altman-Z 26.19
F-Score6
WACC9.45%
ROIC/WACC0.86
Cap/Depr(3y)59.5%
Cap/Depr(5y)45.92%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.7%
Profit Quality(3y)167.06%
Profit Quality(5y)157.56%
High Growth Momentum
Growth
EPS 1Y (TTM)35.57%
EPS 3Y18.08%
EPS 5Y24.47%
EPS Q2Q%30.6%
EPS Next Y34.83%
EPS Next 2Y20.67%
EPS Next 3Y17.47%
EPS Next 5Y16.21%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y17.28%
Revenue growth 5Y22.35%
Sales Q2Q%13.41%
Revenue Next Year16.16%
Revenue Next 2Y14.14%
Revenue Next 3Y13.69%
Revenue Next 5Y13.25%
EBIT growth 1Y59.67%
EBIT growth 3Y4.35%
EBIT growth 5Y14.01%
EBIT Next Year37.82%
EBIT Next 3Y19.86%
EBIT Next 5Y19.36%
FCF growth 1Y39.2%
FCF growth 3Y17.73%
FCF growth 5Y24.08%
OCF growth 1Y39.82%
OCF growth 3Y18.25%
OCF growth 5Y24.01%